id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2006-N-0100-0032,FDA,FDA-2006-N-0100,"Abraxis BioScience, Inc. - Testimony at the October October 10, 2006 Meeting",Other,TS-Testimony,2009-04-02T04:00:00Z,2009,4,2009-04-02T04:00:00Z,,2009-04-02T18:54:59Z,,0,0,0900006480444f9e
FDA-2006-N-0100-0019,FDA,FDA-2006-N-0100,"Cosmetic, Toiletry, and Fragrance Association (CTFA)  - Testimony at the October October 10, 2006 Meeting",Other,TS-Testimony,2009-04-02T04:00:00Z,2009,4,2009-04-02T04:00:00Z,,2009-04-02T16:54:25Z,,0,0,0900006480444f7b
FDA-2006-N-0100-0036,FDA,FDA-2006-N-0100,"SAIC-Frederick, Inc. - Testimony at the October October 10, 2006 Meeting",Other,TS-Testimony,2009-04-02T04:00:00Z,2009,4,2009-04-02T04:00:00Z,,2009-04-02T19:03:38Z,,0,0,0900006480444faa
FDA-2006-N-0100-0023,FDA,FDA-2006-N-0100,"Avidimer Therapeutics - Testimony at the October October 10, 2006 Meeting",Other,TS-Testimony,2009-04-02T04:00:00Z,2009,4,2009-04-02T04:00:00Z,,2009-04-02T18:18:48Z,,0,0,0900006480444f86
FDA-2006-N-0100-0028,FDA,FDA-2006-N-0100,"ETC Group - Testimony at the October October 10, 2006 Meeting",Other,TS-Testimony,2009-04-02T04:00:00Z,2009,4,2009-04-02T04:00:00Z,,2009-04-02T18:42:43Z,,0,0,0900006480444f91
FDA-2006-N-0100-0026,FDA,FDA-2006-N-0100,"Intertox, Inc. - Testimony at the October October 10, 2006 Meeting",Other,TS-Testimony,2009-04-02T04:00:00Z,2009,4,2009-04-02T04:00:00Z,,2009-04-02T18:35:19Z,,0,0,0900006480444f8d
FDA-2006-N-0100-0031,FDA,FDA-2006-N-0100,"University of Queensland - Testimony at the October October 10, 2006 Meeting",Other,TS-Testimony,2009-04-02T04:00:00Z,2009,4,2009-04-02T04:00:00Z,,2009-04-02T18:54:58Z,,0,0,0900006480444f9b
FDA-2006-N-0100-0025,FDA,FDA-2006-N-0100,"International Center for Technology Assessment (CTA) - Testimony at the October October 10, 2006 Meeting",Other,TS-Testimony,2009-04-02T04:00:00Z,2009,4,2009-04-02T04:00:00Z,,2009-04-02T18:35:18Z,,0,0,0900006480444f8b
FDA-2006-N-0100-0021,FDA,FDA-2006-N-0100,"Rice University - Testimony at the October October 10, 2006 Meeting",Other,TS-Testimony,2009-04-02T04:00:00Z,2009,4,2009-04-02T04:00:00Z,,2009-04-02T17:47:38Z,,0,0,0900006480444f82
FDA-2006-N-0100-0020,FDA,FDA-2006-N-0100,"University of Queensland - Testimony at the October October 10, 2006 Meeting",Other,TS-Testimony,2009-04-02T04:00:00Z,2009,4,2009-04-02T04:00:00Z,,2009-04-02T17:40:19Z,,0,0,0900006480444f7d
FDA-2006-N-0100-0030,FDA,FDA-2006-N-0100,"Center for Risk Science and Communication - Testimony at the October October 10, 2006 Meeting",Other,TS-Testimony,2009-04-02T04:00:00Z,2009,4,2009-04-02T04:00:00Z,,2009-04-02T18:54:56Z,,0,0,0900006480444f97
FDA-2006-N-0100-0024,FDA,FDA-2006-N-0100,"Health Canada - Testimony at the October October 10, 2006 Meeting",Other,TS-Testimony,2009-04-02T04:00:00Z,2009,4,2009-04-02T04:00:00Z,,2009-04-02T18:18:50Z,,0,0,0900006480444f89
FDA-2006-N-0100-0034,FDA,FDA-2006-N-0100,"Kereos, Inc. - Testimony at the October October 10, 2006 Meeting",Other,TS-Testimony,2009-04-02T04:00:00Z,2009,4,2009-04-02T04:00:00Z,,2009-04-02T18:55:02Z,,0,0,0900006480444fa4
FDA-2006-N-0100-0041,FDA,FDA-2006-N-0100,"Nanotechnology Characterization Laboratory - Testimony at the October October 10, 2006 Meeting",Other,TS-Testimony,2009-04-02T04:00:00Z,2009,4,2009-04-02T04:00:00Z,,2009-04-02T22:49:02Z,,0,0,0900006480445048
FDA-2006-N-0100-0027,FDA,FDA-2006-N-0100,"Environmental Defense - Testimony at the October October 10, 2006 Meeting",Other,TS-Testimony,2009-04-02T04:00:00Z,2009,4,2009-04-02T04:00:00Z,,2009-04-02T18:42:42Z,,0,0,0900006480444f8f
FDA-2006-N-0100-0040,FDA,FDA-2006-N-0100,"NCI Alliance for Nanotechnology in Cancer - Testimony at the October October 10, 2006 Meeting",Other,TS-Testimony,2009-04-02T04:00:00Z,2009,4,2009-04-02T04:00:00Z,,2009-04-02T22:49:01Z,,0,0,0900006480445045
FDA-2006-N-0100-0039,FDA,FDA-2006-N-0100,"Kobo Products Inc - Testimony at the October October 10, 2006 Meeting",Other,TS-Testimony,2009-04-02T04:00:00Z,2009,4,2009-04-02T04:00:00Z,,2009-04-02T22:39:00Z,,0,0,0900006480445040
FDA-2006-N-0100-0038,FDA,FDA-2006-N-0100,"See FDA-2006-N-0100-0034 - [Kereos, Inc. - Testimony at the October October 10, 2006 Meeting]",Other,TS-Testimony,2009-04-02T04:00:00Z,2009,4,2009-04-02T04:00:00Z,,2009-04-02T19:03:41Z,,0,0,0900006480469594
FDA-2006-N-0100-0022,FDA,FDA-2006-N-0100,"Woodrow Wilson International Center for Scholars - Testimony at the October October 10, 2006 Meeting",Other,TS-Testimony,2009-04-02T04:00:00Z,2009,4,2009-04-02T04:00:00Z,,2009-04-02T18:18:47Z,,0,0,0900006480444f84
FDA-2006-N-0100-0035,FDA,FDA-2006-N-0100,"National Cancer Institute - Testimony at the October October 10, 2006 Meeting",Other,TS-Testimony,2009-04-02T04:00:00Z,2009,4,2009-04-02T04:00:00Z,,2009-04-02T19:03:36Z,,0,0,0900006480444fa6
FDA-2006-N-0100-0033,FDA,FDA-2006-N-0100,"Kobo Products, Inc.- Testimony at the October October 10, 2006 Meeting",Other,TS-Testimony,2009-04-02T04:00:00Z,2009,4,2009-04-02T04:00:00Z,,2009-04-02T18:55:01Z,,0,0,0900006480444fa1
FDA-2006-N-0100-0029,FDA,FDA-2006-N-0100,"BASF Aktiengesellschaft - Testimony at the October October 10, 2006 Meeting",Other,TS-Testimony,2009-04-02T04:00:00Z,2009,4,2009-04-02T04:00:00Z,,2009-04-02T18:42:45Z,,0,0,0900006480444f94
FDA-2006-N-0100-0037,FDA,FDA-2006-N-0100,"University of Oregon - Testimony at the October October 10, 2006 Meeting",Other,TS-Testimony,2009-04-02T04:00:00Z,2009,4,2009-04-02T04:00:00Z,,2009-04-02T19:03:39Z,,0,0,0900006480444fac